The company revealed that its wholly owned subsidiary, Cana Laboratories, has entered into a ten-year contract manufacturing agreement with Provident Pharmaceuticals, a specialty pharmaceutical ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

183k jobs were added to the US economy in January, according to the ADP employment report. And that is a solid 25k above the 148 forecast, or 61k above the initial estimate of 122k. December’s figure ...

He also inspected various production lines, including those for copper communication cables, fiber optics, and factory laboratories. Al-Wazir's next stop was the Utopia Pharmaceuticals Factory ...

Upgrade to begin using 40 years of financial statements and get so much more. Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all ...

TD Cowen Managing Director and Senior Equity Research Analyst John Blackledge joins Catalysts to analyze Amazon's (AMZN) fourth quarter earnings results and share his market outlook. Blackledge ...

New Delhi: With the aim of preventing unethical marketing and ensuring responsible promotion of pharmaceutical products by regulating interactions between doctors / registered medical practitioners ...

AI-powered stock picks with a proven track record to beat the S&P 500.

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.

Jamjoom Pharma 9M 2024 profit up 23% to 304.9M; Q3 at SAR 95M 9 M 2024 Jamjoom Pharma H1 2024 net profit rises to SAR 209.9M; Q2 at SAR 106.7M 6 M 2024 Jamjoom Pharma profit rises 22% to SAR 103M in ...

The drug, called Journavx (suzetrigine) and manufactured by biotech company Vertex Pharmaceuticals, is a non-opioid painkiller, which doesn’t have addictive properties, unlike opioids often used ...